Ngenebio Co., Ltd. is an enterprise in South Korea, with the main office in Seoul. The company operates in the Pharmaceutical and Medicine Manufacturing sector. Ngenebio Co., Ltd. was incorporated on October 30, 2015. The total number of employees is currently 101 - 500 (2025). From the latest financial highlights, Ngenebio Co., Ltd. reported a net sales revenue increase of 30.8% in 2024. Its’ total assets recorded a negative growth of 22.07%. The net profit margin of Ngenebio Co., Ltd. increased by 50.58% in 2024.

Headquarters
303-307, 314Ho, 288, Digital-Ro, Guro-Gu
Seoul; Seoul;

Contact Details: Purchase the Ngenebio Co., Ltd. report to view the information.

Website: http://ngenebio.com

Basic Information

Total Employees:

Purchase the Ngenebio Co., Ltd. report to view the information.

Outstanding Shares:

Purchase the Ngenebio Co., Ltd. report to view the information.

Registered Capital:

Purchase the Ngenebio Co., Ltd. report to view the information.

Financial Auditors:

Purchase the Ngenebio Co., Ltd. report to view the information.

Incorporation Date:

October 30, 2015

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Subsidiaries

(주)진메디카

Company Performance

Financial values in the chart are available after Ngenebio Co., Ltd. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

30.8%▲

Total Operating Revenue

35.59%▲

Operating Profit

-20.33%▼

EBITDA

-6.99%▼

Net Profit/Loss for the Period

-8.42%▼

Total Assets

-22.07%▼

Total Equity

9.08%▲

Operating Profit Margin

24.86%▲

Net Profit Margin

50.58%▲

Return on Equity (ROE)

0.48%▲

Debt / Equity

-19.56%▼

Quick Ratio

-0.29%▼

Cash Ratio

-0.46%▼

Ngenebio Co., Ltd. (South Korea)